O’Keefe, Daniel
Livingston, Michael
Cossar, Reece D.
Kerr, Phoebe
Jacka, David
Dietze, Paul
Article History
Received: 24 March 2022
Accepted: 31 August 2022
First Online: 7 September 2022
Declarations
:
: Not applicable.
: Not applicable.
: PD is supported by NHMRC Research Fellowships (#1136908). PD has received Investigator-Initiated Research funding from Gilead Sciences and an untied educational grant from Indivior unrelated to this study. PD has served as an unpaid member of an advisory board for an intranasal naloxone product. All other authors have nothing to declare.